发色团
体外
天然产物
肽
生物活性
DNA
抄写(语言学)
细胞毒性T细胞
生物
细胞毒性
化学生物学
生物化学
化学
插层(化学)
环肽
达卡霉素
计算生物学
去肽
结构-活动关系
结构母题
药物发现
组合化学
立体化学
链霉菌
作用机理
药品
转录因子
药理学
细胞培养
出处
期刊:ChemMedChem
[Wiley]
日期:2026-07-31
卷期号:21 (15): e70389-e70389
摘要
Actinomycins constitute a class of bioactive compounds known for their potent cytotoxic properties. Among them, actinomycin D, isolated in the 1940s from Streptomyces antibioticus, is the most extensively studied derivative. Structurally, actinomycins are characterized by a planar phenoxazinone chromophore flanked by two cyclic pentapeptides. They exert their biological effects primarily through DNA intercalation and transcription inhibition. Despite its remarkable bioactivity, the clinical application of actinomycin D is limited by significant adverse effects, including hepatotoxicity and restricted selectivity. These limitations underscore the need for structurally optimized analogs with improved therapeutic profiles and reduced toxicity. Over the decades, natural product discovery, precursor-directed biosynthesis, and synthetic modification have yielded more than 70 structurally distinct derivatives, incorporating variations in both the peptide rings and the chromophore core. These structural modifications have resulted in diverse antibacterial, antiviral, and cytotoxic activities. Thus, this review critically examines the historical development, chemical diversity, and in vitro and preclinical bioactivity of actinomycin derivatives, highlighting key structural modifications over time and discussing their implications for future drug development.
科研通智能强力驱动
Strongly Powered by AbleSci AI